North Star Investment Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $97.6K | Buy |
1,109
+1
| +0.1% | +$88 | 0.01% | 526 |
|
|
2025
Q1 | $101K | Hold |
1,108
| – | – | 0.01% | 509 |
|
|
2024
Q4 | $95.6K | Hold |
1,108
| – | – | 0.01% | 515 |
|
|
2024
Q3 | $105K | Buy |
1,108
+61
| +6% | +$5.79K | 0.01% | 497 |
|
|
2024
Q2 | $95.8K | Hold |
1,047
| – | – | 0.01% | 506 |
|
|
2024
Q1 | $94.9K | Buy |
1,047
+1
| +0.1% | +$91 | 0.01% | 515 |
|
|
2023
Q4 | $85.1K | Hold |
1,046
| – | – | 0.01% | 516 |
|
|
2023
Q3 | $83.5K | Buy |
1,046
+1
| +0.1% | +$80 | 0.01% | 518 |
|
|
2023
Q2 | $82.3K | Sell |
1,045
-74
| -7% | -$5.83K | 0.01% | 533 |
|
|
2023
Q1 | $86.9K | Hold |
1,119
| – | – | 0.01% | 531 |
|
|
2022
Q4 | $87K | Hold |
1,119
| – | – | 0.01% | 506 |
|
|
2022
Q3 | $75K | Buy |
1,119
+141
| +14% | +$9.45K | 0.01% | 478 |
|
|
2022
Q2 | $75K | Hold |
978
| – | – | 0.01% | 489 |
|
|
2022
Q1 | $78K | Hold |
978
| – | – | 0.01% | 501 |
|
|
2021
Q4 | $75K | Buy |
978
+1
| +0.1% | +$77 | 0.01% | 533 |
|
|
2021
Q3 | $71K | Hold |
977
| – | – | 0.01% | 527 |
|
|
2021
Q2 | $71K | Buy |
977
+1
| +0.1% | +$73 | 0.01% | 524 |
|
|
2021
Q1 | $67K | Hold |
976
| – | – | 0.01% | 505 |
|
|
2020
Q4 | $65K | Buy |
976
+1
| +0.1% | +$67 | 0.01% | 497 |
|
|
2020
Q3 | $61K | Hold |
975
| – | – | 0.01% | 481 |
|
|
2020
Q2 | $61K | Buy |
975
+1
| +0.1% | +$63 | 0.01% | 465 |
|
|
2020
Q1 | $53K | Sell |
974
-283
| -23% | -$15.4K | 0.01% | 475 |
|
|
2019
Q4 | $81K | Sell |
1,257
-1,244
| -50% | -$80.2K | 0.01% | 467 |
|
|
2019
Q3 | $143K | Buy |
+2,501
| New | +$143K | 0.02% | 383 |
|
|
2019
Q2 | – | Sell |
-1,727
| Closed | -$105K | – | 795 |
|
|
2019
Q1 | $105K | Sell |
1,727
-877
| -34% | -$53.3K | 0.01% | 436 |
|
|
2018
Q4 | $143K | Buy |
2,604
+52
| +2% | +$2.86K | 0.02% | 370 |
|
|
2018
Q3 | $164K | Sell |
2,552
-146
| -5% | -$9.38K | 0.02% | 374 |
|
|
2018
Q2 | $159K | Sell |
2,698
-7
| -0.3% | -$413 | 0.02% | 380 |
|
|
2018
Q1 | $154K | Buy |
2,705
+2,202
| +438% | +$125K | 0.02% | 379 |
|
|
2017
Q4 | $30K | Sell |
503
-88
| -15% | -$5.25K | ﹤0.01% | 639 |
|
|
2017
Q3 | $34K | Buy |
591
+2
| +0.3% | +$115 | ﹤0.01% | 610 |
|
|
2017
Q2 | $35K | Buy |
589
+376
| +177% | +$22.3K | ﹤0.01% | 600 |
|
|
2017
Q1 | $12K | Buy |
213
+35
| +20% | +$1.97K | ﹤0.01% | 778 |
|
|
2016
Q4 | $9K | Sell |
178
-764
| -81% | -$38.6K | ﹤0.01% | 764 |
|
|
2016
Q3 | $54K | Buy |
942
+390
| +71% | +$22.4K | 0.01% | 400 |
|
|
2016
Q2 | $32K | Buy |
552
+202
| +58% | +$11.7K | 0.01% | 464 |
|
|
2016
Q1 | $20K | Buy |
+350
| New | +$20K | ﹤0.01% | 511 |
|